TRIM10 and acute myeloid leukemia: In addition, loss of TRIM10 expression was observed in patients with newly diagnosed AML (n = 120, p < 0.001) and relapsed AML (n = 9, p < 0.001) but not in patients with complete remission (n = 46, Figure 1B).